Stimufend Injection, Solution
Product Images NDC 72603-402

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Stimufend (NDC 72603-402). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure A (Sti0a 0000 01)

Figure A (Sti0a 0000 01)
FDA Label Image

Figure B (Sti0a 0000 02)

Figure B (Sti0a 0000 02)
FDA Label Image

Figure C (Sti0a 0000 03)

Figure C (Sti0a 0000 03)
Not available.*
FDA Label Image

Figure D (Sti0a 0000 04)

Figure D (Sti0a 0000 04)
FDA Label Image

Figure E (Sti0a 0000 05)

Figure E (Sti0a 0000 05)
FDA Label Image

Figure F (Sti0a 0000 06)

Figure F (Sti0a 0000 06)
FDA Label Image

Figures G And H (Sti0a 0000 07)

Figures G And H (Sti0a 0000 07)
FDA Label Image

Figure I (Sti0a 0000 08)

Figure I (Sti0a 0000 08)
FDA Label Image

Figure J (Sti0a 0000 09)

Figure J (Sti0a 0000 09)
FDA Label Image

Figure K (Sti0a 0000 10)

Figure K (Sti0a 0000 10)
FDA Label Image

Figure L (Sti0a 0000 11)

Figure L (Sti0a 0000 11)
FDA Label Image

Figure M (Sti0a 0000 12)

Figure M (Sti0a 0000 12)
FDA Label Image

Figures N And O (Sti0a 0000 13)

Figures N And O (Sti0a 0000 13)
FDA Label Image

Figure P (Sti0a 0000 14)

Figure P (Sti0a 0000 14)
FDA Label Image

Figure Q (Sti0a 0000 15)

Figure Q (Sti0a 0000 15)
FDA Label Image

Figure R (Sti0a 0000 16)

Figure R (Sti0a 0000 16)
FDA Label Image

Package Label – Principal Display – Stimufend –one 0.6 mL Single-dose (Sti0a 0000 17)

Package Label – Principal Display – Stimufend –one 0.6 mL Single-dose (Sti0a 0000 17)
This text appears to be a description of a single-dose pre-filled syringe with a needle guard. It includes information about the active ingredient, storage conditions (refrigerated between 3 to 10°C), inactive ingredients, and warnings not to freeze or shake the product. The text also mentions contacting a doctor for advice on side effects and provides codes to report adverse events. Additionally, there are sections with numerical codes and company names mentioned, which may pertain to product identification or management details.*
FDA Label Image

Package Label – Principal Display – Stimufend – 0.6 mL Single-dose (Sti0a 0000 18)

Package Label – Principal Display – Stimufend – 0.6 mL Single-dose (Sti0a 0000 18)
This text provides information about a medication called StimuFend® Aisling® in a single-dose pre-filled syringe with a dosage of 6 mg / 0.6 mL. It is a recombinant human granulocyte colony-stimulating factor indicated for subcutaneous use only. The product is manufactured by Fresenius Kabi USA, LLC and should be stored refrigerated between 2°C to 8°C. Additionally, the medication should be protected from light and it contains inactive ingredients like acetate, polysorbate 20, and sodium. The product is described as a sterile solution with no preservatives and contains natural rubber.*
FDA Label Image

Package Label – Principal Display – Stimufend – 0.6 mL Single-dose (Sti0a 0000 19)

Package Label – Principal Display – Stimufend – 0.6 mL Single-dose (Sti0a 0000 19)
This is a description of a medication called StimufFend, which is an injection containing 6 mg/0.6 mL of pegfilgrastim-fpgk. The medication was manufactured by Fresenius Kabi USA, LLC in Lake Zurich, Illinois. It is intended for use by Northstar Rx LLC in Memphis, Tennessee. The lot number is XOOXXXX and the expiration date is YYYY-MMM.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.